A quarterly reagents review is more than a stock-take. It is where an in-vitro laboratory confirms that the planned materials match the assay, storage and documentation file. One simple control is easily overlooked: in the basket or requisition, the diluent and the peptide should appear as separate lines. A merged description or vague bundle weakens traceability before the order is placed. These materials are for controlled laboratory research only; they are not for human or veterinary use and must not be treated as medicines, supplements or clinical products.
Why separate lines matter in a research reagents basket
A basket line is a procurement record, not just a click. It connects a specific SKU to a catalogue entry, a batch label, a CoA and a storage instruction. Peptides and diluents are different material classes with different handling implications, so one line cannot carry the same documentary weight for both. Research Sciences lists peptide items individually and lists Bacteriostatic Water 10ml and 10ml Mixing Water wording on the site. That separation lets the reviewer match each peptide to its own batch CoA and each diluent to its own line, quantity and storage note.
The FAQ position is clear that the shop does not supply blended peptides, such as Ipamorelin plus CJC-1295, and recommends buying peptides individually and combining only within a controlled experimental design. A basket showing “peptide with diluent” as one item can obscure whether the peptide SKU is separate, whether the diluent is expected, and whether a blended assumption has crept in. Good procurement mirrors the experimental design: one peptide line per catalogue item, one diluent line per solvent item, and clear quantities.
Traceability depends on labels and records. Vial labels use a reference format combining SKU and expiry date, for example BPC10-03/27, and that reference links to the corresponding CoA; quote it when contacting the shop about documentation. The site’s FAQ notes that a restocked product may carry the same Internal Test Reference (ITR) as earlier stock. An ITR links to associated sample testing reports, but it does not confirm that separate deliveries came from the same production lot or had separate independent testing. Cap colour is not an indicator of identity, quality or origin. Separate basket lines make these checks easier.
For in-vitro workflows, reconstitution planning is a laboratory calculation: diluent volume, target concentration for the assay, and compatibility with the analytical method. The shop’s calculator and preparation tools are for laboratory research use only and must not be used for human or veterinary dosing. A separate diluent line keeps that calculation visible and auditable.
A practical quarterly check for line-level separation
Start with the saved basket or requisition export and compare it with the live catalogue, not last quarter’s assumptions. Each peptide should be a distinct line with its SKU, pack size and quantity; each diluent should be a distinct line with its own description. If the saved basket contains a combined “peptide plus water” description, split it before approval. When rebuilding the list, use the live catalogue to Buy peptides as individual entries so the audit trail reflects the experiment rather than a convenience bundle.
Use a short line-level checklist. For peptides, confirm the product name matches the intended catalogue item, the quantity matches the in-vitro assay plan, and the batch CoA can be identified from the label reference. For diluents, confirm the line names the diluent supplied, such as Bacteriostatic Water 10ml or 10ml Mixing Water, and that it has not been absorbed into the peptide description. Check that diluent quantity has been calculated independently from peptide quantity; do not assume a fixed ratio across different assays. If a listing cites a purity figure, treat it as the shop’s current published wording and reconfirm it against the batch CoA.
Add a “no substitution” note where the assay protocol requires a named diluent or peptide. Ask the approver to initial each line rather than the basket as a whole. Line-level approval also reduces duplicate orders: two peptide lines with similar names can be checked against the protocol, while two diluent lines can be consolidated only if specification and storage conditions are genuinely identical.
Documentation should be checked before the basket is released. The all-products page is the starting point for the current research catalogue, but the batch-specific CoA remains the document to open and check. If a line cannot be matched to a CoA or label reference, pause that line and resolve it with the supplier before approval. The shop’s homepage lists CoAs Janoshik Analytical Reports; open the CoA that accompanies the specific batch rather than treating the basket line as proof of testing.
Documentation, storage and approval notes for the review
The quarterly review is a good moment to align the basket with storage. Lyophilised peptides should be stored at –20°C or below, sealed with desiccant and protected from moisture, heat and light; avoid repeated freeze–thaw cycles. Reconstituted peptides are less stable and should be stored at 2–8°C for short-term laboratory use. A separate diluent line helps the reviewer map storage and handling notes to the correct material instead of applying one storage statement to a combined line.
Approval notes should record the research-use-only status. The shop states that products are labelled “For Research Use Only – Not for Human Consumption” and describes this as its stated position in line with MHRA guidance. That is not legal advice, and the purchaser remains responsible for lawful use, safe handling, storage, disposal and compliance with relevant UK regulations, including COSHH and laboratory safety standards. The review file should show that the materials are for controlled in-vitro research and that the intended use is consistent with purchasing policy.
Common pitfalls are easy to list: a saved basket that still contains a discontinued description; a combined line that hides the diluent; an assumption that two items with the same ITR are the same production lot; a cap colour used as shorthand for identity; or a purity statement copied from a listing without checking the batch CoA. Each is best caught by line-level review. Record the final line-by-line confirmation, including label references and CoA checks, in the quarterly review file so the next review starts from a documented baseline.
For materials managers, the control is straightforward: separate lines, separate checks, separate documentation. The peptide line answers “which batch and which CoA?”; the diluent line answers “which solvent and which volume for the in-vitro method?”. Keeping those questions apart in the basket keeps them apart in the laboratory record. Not for human or veterinary use remains the governing statement for every item in the review.
